BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15841951)

  • 1. [Current role of hormone replacement therapy in the prevention of postmenopausal osteoporosis: gynecologic point of view].
    Tamborini A; Ruiz JC
    Rev Med Interne; 2004 Dec; 25 Suppl 5():S580-7. PubMed ID: 15841951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal hormone replacement therapy: scientific review.
    Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
    JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormone replacement therapy and osteoporosis].
    Takahashi K; Kawagoe J; Ohmichi M; Kurachi H
    Clin Calcium; 2004 Mar; 14(3):436-41. PubMed ID: 15577004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons learned from the WHI: HRT requires a cautious and individualized approach.
    Aubuchon M; Santoro N
    Geriatrics; 2004 Nov; 59(11):22-6. PubMed ID: 15615157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause.
    Lobo RA; Pickar JH; Stevenson JC; Mack WJ; Hodis HN
    Atherosclerosis; 2016 Nov; 254():282-290. PubMed ID: 27745704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Puzzle of hormone replacement therapy and prospect of the role of traditional Chinese medicine in treating postmenopausal syndrome].
    Chen MD; Yang Y
    Zhong Xi Yi Jie He Xue Bao; 2003 May; 1(1):9-11. PubMed ID: 15339602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Justification for the use of HRT in the long-term prevention of osteoporosis.
    Stevenson JC
    Maturitas; 2005 Jun; 51(2):113-26. PubMed ID: 15917151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on the Women's Health Initiative trial of hormone replacement therapy.
    Grimes DA; Lobo RA
    Obstet Gynecol; 2002 Dec; 100(6):1344-53. PubMed ID: 12468183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HRT, osteoporosis and regulatory authorities Quis custodiet ipsos custodes?
    Stevenson JC;
    Hum Reprod; 2006 Jul; 21(7):1668-71. PubMed ID: 16556675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Osteoporosis Society's Position statement on hormone replacement therapy in the prevention and treatment of osteoporosis.
    Bowring CE; Francis RM
    Menopause Int; 2011 Jun; 17(2):63-5. PubMed ID: 21693502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decade post WHI, menopausal hormone therapy comes full circle--need for independent commission.
    Utian WH
    Climacteric; 2012 Aug; 15(4):320-5. PubMed ID: 22762439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial.
    Ness J; Aronow WS; Newkirk E; McDanel D
    J Gerontol A Biol Sci Med Sci; 2005 Apr; 60(4):460-2. PubMed ID: 15933383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
    Stjernquist M;
    Lakartidningen; 2003 May; 100(20):1790-7. PubMed ID: 12806859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of hormone replacement therapy in the asymptomatic postmenopausal woman: what is the current evidence?
    Loh FH
    Ann Acad Med Singap; 2003 Sep; 32(5):605-9; quiz 610. PubMed ID: 14626787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
    Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
    Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of the month. Benefit/risk balance of postmenopausal estrogen-progestin treatment in peril in the Women's Health Initiative study: practical attitude of the clinician].
    Gaspard U; van den Brûle F; Pintiaux A; Foidart JM
    Rev Med Liege; 2002 Aug; 57(8):556-62. PubMed ID: 12405030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone-replacement therapy: current thinking.
    Lobo RA
    Nat Rev Endocrinol; 2017 Apr; 13(4):220-231. PubMed ID: 27716751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evidence of hormone replacement therapy for osteoporosis].
    Tarakida A; Higuchi T; Mizunuma H
    Clin Calcium; 2008 Oct; 18(10):1434-41. PubMed ID: 18830040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.